Percheron Therapeutics LimitedASX: PER

ANP receives US FDA ODD for ATL1102 in DMD

Oct 26, 2020 at 2:12 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment